BE882632A - Substance antibiotique a/16686, sa preparation et son utilisation - Google Patents

Substance antibiotique a/16686, sa preparation et son utilisation

Info

Publication number
BE882632A
BE882632A BE0/200117A BE200117A BE882632A BE 882632 A BE882632 A BE 882632A BE 0/200117 A BE0/200117 A BE 0/200117A BE 200117 A BE200117 A BE 200117A BE 882632 A BE882632 A BE 882632A
Authority
BE
Belgium
Prior art keywords
preparation
antibiotic substance
antibiotic
substance
Prior art date
Application number
BE0/200117A
Other languages
English (en)
French (fr)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of BE882632A publication Critical patent/BE882632A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10GCRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00Catalysts comprising molecular sieves
    • B01J29/04Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/20Silicates
    • C01B33/26Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28Base exchange silicates, e.g. zeolites
    • C01B33/2807Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425Catalysts; their physical properties
    • C07C1/043Catalysts; their physical properties characterised by the composition
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425Catalysts; their physical properties
    • C07C1/043Catalysts; their physical properties characterised by the composition
    • C07C1/0435Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425Catalysts; their physical properties
    • C07C1/043Catalysts; their physical properties characterised by the composition
    • C07C1/0435Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10GCRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00Reforming naphtha
    • C10G35/04Catalytic reforming
    • C10G35/06Catalytic reforming characterised by the catalyst used
    • C10G35/065Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00Catalysts comprising molecular sieves
    • C07C2529/04Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/827Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Geology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE0/200117A 1979-04-07 1980-04-03 Substance antibiotique a/16686, sa preparation et son utilisation BE882632A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07

Publications (1)

Publication Number Publication Date
BE882632A true BE882632A (fr) 1980-10-03

Family

ID=10504421

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/200117A BE882632A (fr) 1979-04-07 1980-04-03 Substance antibiotique a/16686, sa preparation et son utilisation

Country Status (30)

Country Link
US (2) US4303646A (US06534493-20030318-C00166.png)
JP (2) JPS5697237A (US06534493-20030318-C00166.png)
AR (1) AR222217A1 (US06534493-20030318-C00166.png)
AT (1) AT370130B (US06534493-20030318-C00166.png)
AU (2) AU533951B2 (US06534493-20030318-C00166.png)
BE (1) BE882632A (US06534493-20030318-C00166.png)
CA (1) CA1142866A (US06534493-20030318-C00166.png)
CH (1) CH655515B (US06534493-20030318-C00166.png)
DE (1) DE3013246A1 (US06534493-20030318-C00166.png)
DK (1) DK149336C (US06534493-20030318-C00166.png)
ES (1) ES8103170A1 (US06534493-20030318-C00166.png)
FI (1) FI65630C (US06534493-20030318-C00166.png)
FR (1) FR2452931A1 (US06534493-20030318-C00166.png)
GR (1) GR67279B (US06534493-20030318-C00166.png)
HK (1) HK23584A (US06534493-20030318-C00166.png)
HU (1) HU181534B (US06534493-20030318-C00166.png)
IE (1) IE49327B1 (US06534493-20030318-C00166.png)
IL (1) IL59704A (US06534493-20030318-C00166.png)
IT (1) IT1212411B (US06534493-20030318-C00166.png)
LU (1) LU82327A1 (US06534493-20030318-C00166.png)
MX (1) MX5958E (US06534493-20030318-C00166.png)
NL (1) NL192989C (US06534493-20030318-C00166.png)
NO (1) NO155496C (US06534493-20030318-C00166.png)
NZ (1) NZ193357A (US06534493-20030318-C00166.png)
PH (1) PH17230A (US06534493-20030318-C00166.png)
PT (1) PT71064A (US06534493-20030318-C00166.png)
SE (1) SE441188B (US06534493-20030318-C00166.png)
SG (1) SG22687G (US06534493-20030318-C00166.png)
YU (1) YU41917B (US06534493-20030318-C00166.png)
ZA (1) ZA801629B (US06534493-20030318-C00166.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7031T1 (de) 1980-08-16 1984-04-15 Gruppo Lepetit S.P.A. Antibiotikum a/16686 faktor a2, verfahren zu dessen herstellung und die gleichzeitig hergestellten antibiotika a/16686 faktoren a1 und a3.
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
WO2001053533A2 (en) * 2000-01-21 2001-07-26 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
AU2002212014A1 (en) * 2000-10-13 2002-04-22 Ecopia Biosciences Inc. Gene cluster for ramoplanin biosynthesis
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
MXPA04008589A (es) 2002-03-08 2004-12-06 Vicuron Pharm Inc Procedimiento para produccion de derivados de amida tipo ramoplanina.
CA2430580A1 (en) * 2002-04-17 2003-09-04 Ecopia Biosciences Inc. Specialized dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
AU2003240545A1 (en) * 2002-06-06 2003-12-22 Therapeutics Corporation Genome Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
CA2523573A1 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
US20170028016A1 (en) 2014-04-16 2017-02-02 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
SE8002601L (sv) 1980-12-01
DK149336B (da) 1986-05-05
FR2452931B1 (US06534493-20030318-C00166.png) 1983-07-01
HK23584A (en) 1984-03-23
AT370130B (de) 1983-03-10
ES490236A0 (es) 1981-02-16
CA1142866A (en) 1983-03-15
FI65630B (fi) 1984-02-29
FI800881A (fi) 1980-10-08
FR2452931A1 (fr) 1980-10-31
SE441188B (sv) 1985-09-16
AR222217A1 (es) 1981-04-30
YU93580A (en) 1983-06-30
NL192989C (nl) 1998-07-03
IE49327B1 (en) 1985-09-18
NZ193357A (en) 1982-12-07
SG22687G (en) 1989-07-07
ES8103170A1 (es) 1981-02-16
JPS6320514B2 (US06534493-20030318-C00166.png) 1988-04-27
IE800697L (en) 1980-10-07
DE3013246A1 (de) 1980-10-16
IT1212411B (it) 1989-11-22
AU535727B2 (en) 1984-04-05
IL59704A (en) 1983-11-30
NO155496B (no) 1986-12-29
ATA187480A (de) 1982-07-15
JPS62282579A (ja) 1987-12-08
PH17230A (en) 1984-07-03
AU5703680A (en) 1980-10-09
AU533951B2 (en) 1983-12-22
NL192989B (nl) 1998-03-02
AU5903680A (en) 1980-12-11
JPS6251274B2 (US06534493-20030318-C00166.png) 1987-10-29
YU41917B (en) 1988-02-29
GR67279B (US06534493-20030318-C00166.png) 1981-06-26
US4303646A (en) 1981-12-01
US4328316A (en) 1982-05-04
JPS5697237A (en) 1981-08-05
DE3013246C2 (US06534493-20030318-C00166.png) 1987-11-19
IL59704A0 (en) 1980-06-30
NO155496C (no) 1987-04-08
NO800869L (no) 1980-10-08
IT8021162A0 (it) 1980-04-03
MX5958E (es) 1984-09-06
DK149336C (da) 1986-10-13
HU181534B (en) 1983-10-28
CH655515B (US06534493-20030318-C00166.png) 1986-04-30
ZA801629B (en) 1981-03-25
DK140080A (da) 1980-10-08
NL8001982A (nl) 1980-10-09
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
FI65630C (fi) 1984-06-11

Similar Documents

Publication Publication Date Title
BE882632A (fr) Substance antibiotique a/16686, sa preparation et son utilisation
BE884300A (fr) Amides, leur preparation et leur utilisation
ES493480A0 (es) Perfeccionamientos en brazos de manipulacion a distancia
FI801061A (fi) Lunchask foer barn
BE885255A (fr) Composes de 10-deazaminopterine, leur preparation et leur utilisation
TR21804A (tr) Zirai uereler ve izouereler
DK209180A (da) Sortereapparat
FR2457123B1 (fr) Extrudeuse et son utilisation
PH15911A (en) Novel substituted phenoxy benzyloxycarbonyl derivatives and their use as insecticides and acaricides
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
LU79452A1 (fr) Procede de preparation de l'antibiotique n-acetyl-deshydrothienamycine et son utilisation
TR20198A (tr) X azolil-b hidroksi-ketonlar,imallerine mahsus bir usul ve fungisidler olarak kullanilmalari
BE879170A (fr) Nouvel antibiotique sb-72310, sa preparation et son utilisation
SE8003485L (sv) Pyrazinobensodiazepiner, deras framstellning och anvendning
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
GB2060629B (en) Antibiotic substance and production and use thereof
FI803002A (fi) 2-amino-3-benzoyl-fenylacetamider och cykliska homologer
BE880282A (fr) 4,1-benzoxazepines et 4,1-benzothiazepines
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
IT1166681B (it) Piretroidi
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
IT1141632B (it) Antibiotico marcrolidico e procedimento per la sua preparazione
FI802198A (fi) Antibiotiska foereningar

Legal Events

Date Code Title Description
CA Change of address of the owner of the patent

Owner name: *BIOSEARCH ITALIA S.P.A.:VIA R. LEPETIT 34, I-2104

Effective date: 19981210

RE20 Patent expired

Owner name: BIOSEARCH ITALIA S.P.A.

Effective date: 20000403